Kimberly Blackwell

Insider Reports History

Location
New York, NY
Signature
/s/ Markus Warmuth, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kimberly Blackwell:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zentalis Pharmaceuticals, Inc. Chief Executive Officer, Director Common Stock 484,145 $5,659,655 $11.69 01 Feb 2024 Direct
Zentalis Pharmaceuticals, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 250,000 01 Feb 2024 Direct
Century Therapeutics, Inc. Director Stock Option (right to buy) 44,000 12 Jun 2025 Direct
Monte Rosa Therapeutics, Inc. Director Stock Option (Right to Buy) 30,700 13 Jun 2025 Direct

Insider Reports Filed by Kimberly Blackwell

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GLUE Monte Rosa Therapeutics, Inc. 13 Jun 2025 1 $0 4 Director 16 Jun 2025, 16:05
IPSC Century Therapeutics, Inc. 12 Jun 2025 1 $0 4 Director 16 Jun 2025, 18:26
IPSC Century Therapeutics, Inc. 20 Jun 2024 1 $0 4 Director 21 Jun 2024, 16:48
GLUE Monte Rosa Therapeutics, Inc. 12 Jun 2024 1 $0 4 Director 13 Jun 2024, 16:30
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2024 3 -$241,457 4 Chief Executive Officer, Director 05 Feb 2024, 19:11
ZNTL Zentalis Pharmaceuticals, Inc. 13 Nov 2023 1 +$51,448 4 Chief Executive Officer, Director 13 Nov 2023, 17:24
IPSC Century Therapeutics, Inc. 27 Jun 2023 1 $0 4 Director 29 Jun 2023, 16:20
GLUE Monte Rosa Therapeutics, Inc. 14 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:26
ZNTL Zentalis Pharmaceuticals, Inc. 01 Feb 2023 2 $0 4 Chief Executive Officer, Director 01 Feb 2023, 18:08
GLUE Monte Rosa Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 16:30
IPSC Century Therapeutics, Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:23
ZNTL Zentalis Pharmaceuticals, Inc. 16 May 2022 2 $0 4 President & CEO, Director 20 May 2022, 16:27
ZNTL Zentalis Pharmaceuticals, Inc. 03 Jan 2022 3 -$35,940 4 Director 05 Jan 2022, 16:49
ZNTL Zentalis Pharmaceuticals, Inc. 01 Dec 2021 3 -$34,040 4 Director 02 Dec 2021, 18:16
ZNTL Zentalis Pharmaceuticals, Inc. 01 Nov 2021 3 -$32,660 4 Director 02 Nov 2021, 19:24
ZNTL Zentalis Pharmaceuticals, Inc. 25 Oct 2021 3 -$77,590 4 Director 27 Oct 2021, 20:13
GLUE Monte Rosa Therapeutics, Inc. 23 Jun 2021 0 $0 3 Director 23 Jun 2021, 20:40
IPSC Century Therapeutics, Inc. 17 Jun 2021 1 $0 4 Director 21 Jun 2021, 16:34
IPSC Century Therapeutics, Inc. 17 Jun 2021 0 $0 3 Director 17 Jun 2021, 17:07
ZNTL Zentalis Pharmaceuticals, Inc. 04 Jun 2021 2 $0 4 Director 08 Jun 2021, 17:27
GLUE Monte Rosa Therapeutics, Inc. 12 Apr 2021 2 $0 4 Director 25 Jun 2021, 17:00